Am I at risk for
prostate cancer?
Do I need to
get a biopsy?
I've been diagnosed.
What should I do?
What Should I
Ask My Doctor?

Understanding Prostate Cancer

1 in 7 Men Will Be Diagnosed

Although prostate cancer is the most common non-skin cancer in America, most men diagnosed will not die from the disease.

What are YOUR risks?

learn more

Am I at risk for
prostate cancer?

1 in 7 Men Will Be Diagnosed

Although prostate cancer is the most common non-skin cancer in America, most men diagnosed will not die from the disease.

What are YOUR risks?

learn more

The Prostate Biopsy

A prostate biopsy is a procedure to remove suspicious prostate gland tissue samples in order to determine if cancer or other abnormal cells are present.

Most prostate biopsies can take place within your urologist’s office.

learn more

Do I need to
get a biopsy?

The Prostate Biopsy

learn more

A Positive Diagnosis

Although you were positively diagnosed with prostate cancer, it’s helpful to understand your specific prostate cancer in order to determine the right path of treatment for you.

Be proactive. Learn more about your specific disease.

learn more

I've been diagnosed.
What should I do?

A Positive Diagnosis

learn more

More Information for Better Decisions

Make sure you know the facts and understand all of your options. Review this list of questions to ask your doctor.

Looking for more information about prostate cancer? There are many reputable organizations which can provide additional information and resources.

learn more

What Should I
Ask My Doctor?

More Information for Better Decisions

learn more

Advanced diagnostic and prognostic solutions for urological cancer care

No matter which test(s) you receive from our growing portfolio of traditional and breakthrough products and services, rest assured they are backed by our superior clinical expertise and the
highest level of customer support.

Press Release

Metamark Receives Positive Medicare Final Coverage Decision for ProMark

Metamark Genetics, Inc. today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses novel molecular diagnostic technologies, has issued final local coverage determination (LCD) for ProMark®, the first and only proteomic prognostic test for early-stage prostate cancer.

read article

Press Release

Metamark Announces Agreement with Anthem Blue Cross Blue Shield of Georgia

Metamark Genetics, Inc., a leader in providing critical diagnostic and prognostic information to enable more informed treatment decisions for urological cancer, today announced that effective May 25, 2016, the Company has signed an agreement with Anthem Blue Cross Blue Shield of Georgia.

read article

Displaying results 1-2 (of 12)

|< < 1 - 2 - 3 - 4 - 5 - 6 > >|